BCRX
BioCryst Pharmaceuticals Inc
8.60$
-2.4%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 96.1% | 95.9% | 95.6% | 76.9% | 86.9% | 86.0% | 85.4% | 87.2% | 79.7% | 78.6% | 80.3% | 86.9% | |
| 28.9% | 21.4% | 18.0% | 16.6% | 19.9% | 21.4% | 22.0% | 19.3% | 18.8% | 17.5% | 37.1% | 27.8% | |
| 76.0% | 75.2% | 71.9% | 57.6% | 67.3% | 65.5% | 61.5% | 56.9% | 47.7% | 53.4% | 51.4% | 63.2% | |
| 10.3% | 11.0% | 12.9% | 14.6% | 14.7% | 16.1% | 19.5% | 19.9% | 20.5% | 20.8% | 23.5% | 19.9% | |
| 5.7% | 5.5% | 6.4% | 0.9% | 1.5% | 1.6% | 1.4% | 1.1% | 1.2% | 1.0% | 1.3% | 1.1% | |
| 178.6% | 188.1% | 201.8% | 200.7% | 195.4% | 197.0% | 194.1% | 192.2% | 186.9% | 123.2% | 219.1% | 181.4% | |
| 17.4% | 29.0% | 25.6% | 27.3% | 31.3% | 32.7% | 29.1% | 38.7% | 42.6% | 38.1% | 42.0% | 37.4% | |
| 0.4% | 0.5% | 0.6% | 0.6% | 7.3% | 7.2% | 7.7% | 0.4% | 8.8% | 0.3% | 9.3% | 0.5% | |
| 2.0% | 4.0% | 2.5% | 1.6% | 2.7% | 2.4% | 2.1% | 1.9% | 1.2% | 3.1% | 2.4% | 2.1% | |
| 159.3% | 156.9% | 173.8% | 171.1% | 162.1% | 162.3% | 162.9% | 151.1% | 141.9% | 83.1% | 172.5% | 139.5% | |
| -78.6% | -88.1% | -101.8% | -100.7% | -95.4% | -97.0% | -94.1% | -92.2% | -86.9% | -23.2% | -119.1% | -81.4% | |
| -309.7% | -325.2% | -366.9% | -366.0% | -354.9% | -360.9% | -368.7% | -386.0% | -392.5% | -292.9% | -479.1% | -385.3% | |
| 36.3% | 39.0% | 44.0% | 43.7% | 42.1% | 42.3% | 44.8% | 48.1% | 49.3% | 42.6% | 52.1% | 47.5% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.